Acinetobacter baumannii is an important opportunistic pathogen responsible for nosocomial outbreaks, mostly occurring in intensive care units. Due to the multiplicity of infection sources, reliable molecular fingerprinting techniques are needed to establish epidemiological correlations among A. baumannii isolates. Multiple-locus variable-number tandem-repeat analysis (MLVA) has proven to be a fast, reliable, and costeffective typing method for several bacterial species. In this study, an MLVA assay compatible with simple PCR-and agarose gel-based electrophoresis steps as well as with high-throughput automated methods was developed for A. baumannii typing. Preliminarily, 10 potential polymorphic variable-number tandem repeats (VNTRs) were identified upon bioinformatic screening of six annotated genome sequences of A. baumannii. A collection of 7 reference strains plus 18 well-characterized isolates, including unique types and representatives of the three international A. baumannii lineages, was then evaluated in a two-center study aimed at validating the MLVA assay and comparing it with other genotyping assays, namely, macrorestriction analysis with pulsed-field gel electrophoresis (PFGE) and PCR-based sequence group (SG) profiling. The results showed that MLVA can discriminate between isolates with identical PFGE types and SG profiles. A panel of eight VNTR markers was selected, all showing the ability to be amplified and good amounts of polymorphism in the majority of strains. Independently generated MLVA profiles, composed of an ordered string of allele numbers corresponding to the number of repeats at each VNTR locus, were concordant between centers. Typeability, reproducibility, stability, discriminatory power, and epidemiological concordance were excellent. A database containing information and MLVA profiles for several A. baumannii strains is available from http://mlva.u-psud.fr/.The Gram-negative bacterium Acinetobacter baumannii has emerged worldwide as a major nosocomial pathogen and a serious threat to patients in intensive care units (ICUs) (18,27). Hallmarks of A. baumannii infection are resistance to a broad range of antimicrobial agents, the tendency for epidemic spread, and long-term persistence in the hospital setting (4,8,27).Most A. baumannii clinical strains from multiple hospital outbreaks throughout the world have been referred to a few epidemic lineages. Two of these, called international clonal lineages I and II, were first identified in northwestern Europe in the early 1980s and then worldwide (8, 17), while a third clone, called international clonal lineage III, was later detected in France, Netherlands, Italy, and Spain, probably persisting in European hospitals since the 1990s (17, 34).Several typing methods have been developed to trace A. baumannii epidemiology from the local to the global scale. Among them, macrorestriction analysis with pulsed-field gel electrophoresis (PFGE) (23) and multilocus sequence typing (MLST) (2, 7) are currently considered the methods of choice for epidemi...